---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-015242"
form_type: "8-K"
ticker: "PURE"
cik: "0001006028"
company_name: "PURE BIOSCIENCE, INC."
filed_at: "2025-06-16T23:59:59+00:00"
generated_at: "2026-05-19T05:54:06.418743+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# PURE Bioscience Q3 net product sales up 11% YoY; net loss narrows to $580K

## Summary
- Net product sales $489K in fiscal Q3 ended Apr 30, 2025, up from $440K YoY.
- Net loss improved to $580K from $857K in same quarter last year.
- Adjusted net loss (excl. share-based comp) was $547K vs $825K YoY.
- EPS remained ($0.01) for both quarters; nine-month EPS ($0.02) vs ($0.03) last year.
- CEO reports SDC dairy membrane solution now commercial at full-scale dairy plants.

## SEC filing metadata
- accession: 0001641172-25-015242
- form_type: 8-K
- ticker: PURE
- cik: 0001006028
- company_name: PURE BIOSCIENCE, INC.
- filed_at: 2025-06-16T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006028/000164117225015242/0001641172-25-015242-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006028/000164117225015242/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-015242
- JSON: https://secwatch.observer/filing/0001641172-25-015242.json
- Plain text: https://secwatch.observer/filing/0001641172-25-015242.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.